The Japanese Society of Nuclear Medicine (JSNM) was established in 1964.
The main aim of JSNM is the appropriate development of applications for radioactive substances and stable nuclides in medicine. Towards this end, JSNM promotes the exchange of ideas information, and research in nuclear medicine. JSNM is interested in international collaboration for the development of nuclear medicine. Through its activities, JSNM contributes to the development of medicine and society, not only in Japan but also around the world.
JSNM currently has over 3,500 members, comprising physicians, physicists, chemists, pharmacists, technologists, and others interested in the clinical and investigational use of radiopharmaceuticals and related fields. The JSNM membership provides exclusive professional, educational and personal benefits.
JSNM publishes two journals: Kakuigaku, and Annals of Nuclear Medicine (ANM). Kakuigaku is published in Japanese (although Figure Legends, Tables, and Summaries are given in English), whereas ANM is published in English.
ANM is indexed in both Current Contents and MEDLINE. ANM indices and article abstracts are available on this website.
The Annual Meeting is held every Autumn. The President of each meeting prepares international sessions.
JSNM comprises six regional chapters where local activities are organized, and includes eight Committees and four Councils.
Every regional chapter and committee and council organizes its own activities, including publications and meetings.